FDA Staff Weighs In on Potential First mRNA Flu Shot
Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna’s mRNA flu vaccine candidate for adults 50 and older, which has…
Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna’s mRNA flu vaccine candidate for adults 50 and older, which has…
Compare health Insurance & supplemental plans from trusted insurance providers. Get personalized quotes in minutes and speak with a licensed agent today.
Enter your ZIP code to see plans available in your area.
